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Nutrition and Cancer
Biotinylation of K12 in Histone H4 Decreases in Response to DNA
Double-Strand Breaks in Human JAr Choriocarcinoma Cells1,2
Nagarama Kothapalli,* Gautam Sarath,† and Janos Zempleni* **3
*Department of Biochemistry, †U.S. Department of Agriculture-ARS and Department of Entomology,
and **Departments of Nutrition and Health Sciences, and Animal Science, University of Nebraska
at Lincoln, Lincoln, NE
ABSTRACT We tested the hypothesis that biotinylation of K12 in histone H4 plays a role in the cellular response
to double-strand breaks (DSB) of DNA in human cells. DSB were caused by treating choriocarcinoma JAr cells with
etoposide. Biotinylation of K12 in histone H4 decreased by 50% as early as 10–20 min after initiation of treatment
with etoposide. Biotinylation returned to initial levels 30–40 min after the addition of etoposide to the medium.
Temporal patterns of K12-biotinylation were similar for human lymphoma cells. Phosphorylation of S14 of histone
H2B and poly(ADP-ribosylation) of glutamate residues on histone H2A are known markers of DSB in DNA; these
modifications increased 10–40 min after alterations in K12-biotinylation occurred. Decreased biotinylation of K12
of histone H4 was specific for DSB but was not detectable in response to single-strand breaks or the formation of
thymine dimers. Biotin-deficient choriocarcinoma cells exhibited a 40% decrease in rates of survival in response
to etoposide compared with biotin-sufficient controls. These studies suggest that the lack of biotinylation of K12
in histone H4 is an early signaling event in response to DSB. J. Nutr. 135: 2337–2342, 2005.
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In eukaryotic cell nuclei, DNA associates with histones
H2A, H2B, H3, and H4 to form nucleosomal core particles.
Histones may undergo various post-translational modifications
in their N-termini. These modifications include acetylation
(1–3), methylation (4), phosphorylation (4), ubiquitination
(4), and poly(ADP-ribosylation) (5–7) of -amino groups,
guanidino groups, carboxyl groups, and hydroxyl groups. Dis-
tinct patterns of modifications of individual histones, nucleo-
somal core particles, and chromosomal domains play unique
roles in chromatin structure, cell signaling, and genomic sta-
bility (8,9). Histone modifications may affect each other in
synergistic or antagonistic ways. For example, acetylation of
K23 mediates methylation of R17 in histone H3 (10).
There is increasing evidence that histones are also co-
valently modified by the vitamin biotin (11–13), mediated by
holocarboxylase synthetase (14) and biotinidase (11). The
following biotinylation sites were identified in human his-
tones: K9 and K13 in histone H2A (15); K4, K9, and K18 in
histone H3 (16); and K8 and K12 in histone H4 (13). Bioti-
nylation of histones plays a role in processes such as cell
proliferation (12,14), gene silencing (17), and the cellular
response to UV-induced DNA damage (17).
Various cellular events and environmental insults may
cause DNA damage. For example, UV light may trigger the
formation of thymine dimers, whereas the antineoplastic agent
etoposide inhibits topoisomerase II, mediating double-strand
breaks (DSB)4 of DNA. Damaged DNA causes chromosomal
abnormalities, potentially leading to malignant transforma-
tions. The risk for propagation of premalignant cells is reduced
by activation of the following pathways in response to DNA
damage: 1) activation of DNA repair mechanisms, which
mediate the removal of DNA lesions (18); and 2) activation of
apoptotic cascades, which mediate the elimination of prema-
lignant cells if DNA damage is beyond repair (19). Histone
modifications play a crucial role in these processes. For exam-
ple, DNA damage causes poly(ADP-ribosylation) of histones,
recruiting DNA repair proteins to sites of DNA damage (20).
These proteins participate in base excision repair (21) and
nucleotide repair pathways (22).
Here, we tested the hypothesis that biotinylation of histone
H4 plays a role in the cellular response to DSB of DNA.
Specifically we determined 1) whether etoposide-induced DSB
are associated with alterations of K12 biotinylation in histone
H4 in cells originally derived from various human tissues; 2)
whether putative changes of K12 biotinylation in histone H4
are specific for DSB or whether similar changes are observed in
response to the formation of thymine dimers and single-strand
breaks; and 3) whether biotin concentrations in culture media
affect cell survival in response to DSB in DNA.
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and 1 P20 RR16469, and by the National Science Foundation EPSCoR grant
EPS-0346476. This paper is a contribution of University of Nebraska-Agricultural
Research Division, Lincoln, NE 68583 (Journal Series no. 14530).
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MATERIALS AND METHODS
Cell culture. Human choriocarcinoma (JAr) cells and lymphoid
(Jurkat) cells (ATCC) were cultured in biotin-supplemented medium
(2 mol/L) as described (23,24). JAr cells were harvested at 60–80%
confluence for subsequent analyses. Culture media were supple-
mented with sodium butyrate (5 mmol/L) for 24 h to inhibit histone
deacetylases if samples were analyzed for acetylated histones. For
survival studies, biotin-deficient JAr cells were obtained by culturing
cells in biotin-deficient medium (0.025 nmol/L) for 3 wk as described
(23); cells cultured in medium containing a physiologic concentra-
tion of biotin (0.25 nmol/L) were used as control.
DNA damage. Cells were treated with 60 nmol/L etoposide for
up to 2 h to cause DSB in DNA (25). Specificity controls were treated
as follows: 20 nmol/L doxorubicin for up to 2 h to cause DSB in DNA
(26); 0.15 mmol/L zeocin to cause single-stranded DNA breaks (27);
and UV light (500 mJ/m2) for 30 s (28) to cause the formation of
thymine dimers. At timed intervals, cells were collected for analyses
as described below.
Etoposide is an inhibitor of topoisomerase II, causing DSB at the
replication fork and G2 phase arrest (25). Theoretically, etoposide
will not cause DSB until the replication fork is formed in the S phase
of the cell cycle. Hence, etoposide-resistant controls were generated
by treating cells with hydroxyurea (2 mmol/L) for 30 h to cause G1
arrest (29) before treatment with 60 nmol/L etoposide. G1 arrest was
confirmed by staining with propidium iodide and flow cytometry
(Cell Analysis Facility, University of Nebraska Medical Center) as
described (30).
In some experiments, we determined whether biotin deficiency
decreased the survival of etoposide-treated JAr cells. In these exper-
iments, biotin-deficient cells and biotin-sufficient controls were
treated with 6 nmol/L etoposide, and cell viability was quantified at
timed intervals using trypan blue exclusion (31).
Histone analysis. Nuclear histones were extracted from JAr and
Jurkat cells using 1 mol/L HCl (12). For analysis of phosphorylated
histones, 1 mmol/L sodium vanadate was added to the HCl used for
extraction. Equal amounts of histones (as judged by gel densitometry
after staining with Coomassie blue) were resolved by using 18% Tris
glycine gels (Invitrogen). Proteins were electroblotted onto polyvi-
nylidene fluoride membranes; histone modifications were probed us-
ing the following primary antibodies: rabbit anti-human biotinyl-K12
histone H4 (13), rabbit anti-human acetyl-K12 histone H4, rabbit
anti-human dimethyl-K4 histone H3, rabbit anti-human phospho-
S14 histone H2B, and mouse anti-human ubiquitinyl-histone H2A
(Upstate). Antibody binding was visualized using appropriate horse-
radish peroxidase-labeled secondary antibodies and chemilumines-
cence; gel densitometry was used for quantification (32). If bands
were too faint for detection by gel densitometry, we used half the
detection limit for data analysis.
Poly(ADP-ribosylation) of histones is mediated by poly(ADP-
ribose) polymerase using NAD as a substrate (20). For analysis of
poly(ADP-ribosylation) of histones, JAr cell nuclei were isolated as
described (33). Nuclei were incubated with [32P]NAD for 5 min,
followed by incubation with 60 nmol/L etoposide for up to 2 h (33)
The reaction was quenched using 10 mmol/L nicotinamide (33).
Histones were isolated using acid extraction (12), and poly(ADP)ri-
bosylated histones were quantified by autoradiography and gel den-
sitometry.
Analysis of DNA breaks. Cells were grown on microscope
coverslips for treatment with etoposide as described above. Positive
controls were treated with 1 mol/L DNase for 10 min at room
temperature. DNA breaks were visualized by TDT-mediated dUTP
nick end labeling (TUNEL) using a commercial kit (ApoAlert-DNA
Fragmentation Assay; BD Biosciences). DNA strand breaks appear in
green color due to the incorporation of fluorescein-labeled nucleo-
tides at nicked ends. Images were obtained using an Olympus FV500
confocal microscope (Microscopy Core Facility, University of Ne-
braska-Lincoln).
Immunocytochemistry. Intracellular histone H4 was visualized
using standard procedures of immunocytochemistry (34). Anti-hu-
man biotinyl-K12 histone H4 antibody (13) and Cy™2-conjugated
donkey anti-rabbit IgG (Jackson ImmunoResearch) were used for
staining. The cytoplasmic compartment was stained using rhodamine
phalloidin (Molecular Probes), and nuclei were stained with 4,6-
diamidino-2-phenylindole (DAPI). S14-phosphorylated histone H2B
is a known marker for DNA damage (34) and was visualized using
rabbit anti-human phospho-S14 H2B and Cy2-conjugated donkey
anti-rabbit IgG (positive control). Images were obtained by using an
Olympus FV500 confocal microscope (Microscopy Core Facility,
University of Nebraska-Lincoln).
Biotin-dependent carboxylase. Biotin-dependent carboxylases
are good markers for cellular biotin (35). Biotinylated carboxylases in
cell extracts were resolved by PAGE and probed using streptavidin
peroxidase (24)
Statistics. Homogeneity of variances among groups was tested
using Bartlett’s test (36). If variances were heterogeneous, the data
were log-transformed before further statistical analysis. Significance of
differences among groups was tested by one-way ANOVA. Fisher’s
Protected Least Significant Difference procedure was used for post-
hoc testing (36). Effects of treatment over time (survival experiment)
were analyzed by repeated-measures ANOVA, followed by pairwise
comparison of time points (e.g., biotin-deficient vs. biotin-sufficient
cells at time 6 h) by paired t test (36). StatView 5.0.1 (SAS Institute)
was used to perform all calculations. Differences were considered
significant if P  0.05.
RESULTS
Biotinylation of K12 in histone H4 decreased rapidly but
transiently in response to treatment with etoposide in JAr
cells. Specifically, biotinylation of K12 in histone H4 de-
creased by 50% as early as 10–20 min after initiation of
treatment with etoposide (Fig. 1 and online Supplemental
Table 1). Biotinylation of K12 returned to pretreatment levels
within 30–40 min after addition of etoposide to culture media.
Biotinylation of K12 in histone H4 appears to be an early
signaling event in response to DNA damage. This notion is
based on a comparison of the time course of K12-biotinylation
with the time courses of other known markers of DNA damage
(7,34). First, phosphorylation of S14 in histone H2B increased
from barely detectable levels at zero time to detectable levels
0 min after the addition of etoposide to culture media (Fig.
1 and online Supplemental Table 1). Second, poly(ADP-
ribosylation) of histone H2A increased from barely detectable
levels at zero time to maximal levels 60 min after the addition
of etoposide to culture media. Hence, these 2 markers of DNA
damage were detectable 10–40 min after alterations in K12
biotinylation occurred.
DSB of DNA caused specific time-dependent modifications
of histones as opposed to global changes in histone modifica-
tions. For example, treatment of JAr cells with etoposide did
not affect the abundance of K4-dimethylation of histone H3
and poly(ubiquitination) of histone H2A (Fig. 1 and online
Supplemental Table 1), strongly suggesting that changes in
biotinylation of K12 on histone H4 were an early indicator of
DSB in DNA in response to etoposide treatment. The occur-
rence of DSB of DNA was confirmed by TUNEL assay. DNA
breaks were detectable 60 min after the addition of etoposide
to culture media, but some damage probably occurred earlier
(Fig. 2).
Biotinylation of K12 in histone H4 did not change in
response to etoposide treatment in G1 phase-arrested JAr cells
(Fig. 3). We compared temporal patterns of K12-biotinylation
in G1 phase-arrested JAr cells and a mixed population of
asynchronous JAr cells. G1 arrest by hydroxyurea treatment
was confirmed using flow cytometry (Fig. 3, top row). Note that
etoposide causes DSB only during the S phase of the cell cycle
(25). Consistent with this notion, treatment with etoposide
did not affect biotinylation of K12 in histone H4 in G1-
arrested cells, but caused a substantial decrease in K12-biotin-
ylated histone H4 in asynchronous cells (Fig. 3, bottom row).
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Immunocytochemistry experiments were consistent with
the hypothesis that decreased biotinylation of K12 in histone
H4 is an early signaling event in response to DSB. First, we
confirmed the localization of K12-biotinylated histone H4 in
untreated JAr cells (Fig. 4A). Preimmune serum did not
produce a detectable signal for K12-biotinylated histone H4
(data not shown). Second, we monitored the temporal pat-
terns of K12-biotinylated histone H4 and S14-phosphorylated
histone H2B (control) in response to etoposide. Decreased
biotinylation of K12 was detectable as early as 20 min after the
addition of etoposide to culture media (Fig. 4B). The abun-
dance of S14-phosphorylated histone H2B increased 60 min
after the addition of etoposide to culture media (data not
shown).
Decreased K12-biotinylation of histone H4 in response to
DSB is a ubiquitous phenomenon as opposed to being a tissue-
specific event. For example, in lymphoid (Jurkat) cells treated
with etoposide, there was a decrease of K12-biotinylation
similar to the decrease in JAr cells. K12-biotinylation of his-
tone H4 in Jurkat cells reached a low 40 min after addition
of etoposide to the culture medium (Fig. 5A).
Decreased biotinylation of K12 in histone H4 is specific for
DSB as opposed to being a global marker for various kinds of
DNA damage. First, when formation of thymine dimers in
DNA was caused by UV treatment of JAr cells, biotinylation
of K12 in histone H4 increased for at least 120 min (Fig. 5B).
Second, if single-strand breaks of DNA were caused by treat-
ment of JAr cells with zeocin, K12-biotinylation in histone H4
did not change substantially (Fig. 5B). In contrast, if DSB of
DNA were caused by treatment of JAr cells with doxorubicin,
the temporal pattern of K12-biotinylation in histone H4 was
similar to the pattern seen after treatment with etoposide (Fig.
5B). These observations are consistent with the notion that
alterations of K12-biotinylation are specific for the kind of
DNA damage, but not for the agent used to cause the damage.
Biotin deficiency was associated with decreased cell survival
in response to treatment with etoposide. Here, cells were
cultured in biotin-sufficient or biotin-deficient media for 21 d.
First, we confirmed that biotin concentrations in culture me-
dia affected intracellular biotin concentrations. The abun-
dance of biotinylated pyruvate carboxylase, propionyl-CoA
carboxylase (-chain), and 3-methylcrotonyl-CoA carboxy-
lase (-chain) was substantially greater in cells from biotin-
sufficient medium than in cells from biotin-deficient medium
(Fig. 6A). Note that propionyl-CoA carboxylase and 3-meth-
ylcrotonyl-CoA carboxylase were not resolved by the electro-
phoresis procedure used and migrated as a single band. Acetyl-
CoA carboxylase was not detectable in JAr cells, consistent
with previous studies in this cell line (23). Next, biotin-
defined cells were exposed to 6 nmol/L etoposide, and cell
survival was monitored at timed intervals. Cells cultured in
biotin-sufficient medium had greater survival rates than cells
cultured in biotin-deficient medium (Fig. 6B). For example,
6 h after the addition of etoposide to culture media, 64  14%
of biotin-sufficient cells were still alive, whereas only 38
 11% of biotin-deficient cells were still alive. These effects
cannot be explained by the effects of biotin deficiency on
proliferation rates, which are moderate (23,24,37).
DISCUSSION
Cells are constantly exposed to environmental insults that
may cause DSB of DNA. Cells respond to DSB by activating
repair pathways that depend on alterations of chromatin struc-
ture (38). Histone modifications play a key role in mediating
these chromatin remodeling events. Previous studies identified
some of the histone modifications that occur in response to
DSB in mammalian cells, e.g., phosphorylation of S14 in
histone H2B, phosphorylation of S139 in histone H2AX, and
poly(ADP-ribosylation) of glutamate residues in histone H2A
(20,34,39). The present study expands the list of damage-
dependent histone modifications by unveiling a temporal pat-
tern of K12-biotinylation in histone H4 in response to DSB in
human cells.
This is the first time that a correlation was shown between
the biotinylation of a distinct lysine residue in a human
histone and a physiologic event that requires chromatin re-
modeling. In previous studies, streptavidin peroxidase was used
as a probe for biotin to provide circumstantial evidence for
biological functions of histone biotinylation in cell prolifera-
tion and UV-induced DNA damage (12,17). Streptavidin
binds to biotin in general and does not permit pinpointing
distinct biotinylation sites in histones, e.g., K8 and K12 in
histone H4 (13). In contrast, the site-specific antibody to
FIGURE 1 Biotinylation of K12 in histone H4 decreases rapidly
and transiently in response to treatment with etoposide in JAr cells.
Biotinylation of K12 in histone H4, phosphorylation of S14 in histone
H2B, dimethylation of K4 in histone H3, and poly-ubiquitination of
histone H2A were visualized by Western blot analysis at timed intervals
after addition of etoposide to culture medium. Poly(ADP-ribosylation) of
histone H2A was visualized using autoradiography after etoposide
addition. Representative gels from at least 3 repeats are depicted.
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K12-biotinylated histone H4 as a probe used in this study
indicates the physiologic relevance of biotinylation of K12 in
histone H4 in DNA repair signaling.
Specifically, this study provides evidence 1) that a transient
decrease of K12-biotinylation in histone H4 is an early signal-
ing event in response to DSB; 2) that signaling by biotinyla-
tion of K12 is a universal rather than a tissue-specific mech-
anism in humans; 3) that biotinylation of K12 in histone H4
decreases specifically in response to DSB but does not decrease
in response to single-strand breaks or formation of thymine
dimers; and 4) that biotin deficiency is associated with de-
creased cell survival in response to DSB.
The decreased biotinylation of K12 in histone H4 in re-
sponse to DSB occurs before phosphorylation of S14 in histone
H2B and potentially ahead of or in concert with poly(ADP-
ribosylation) of glutamate residues in histone H2A. Currently,
it is unknown whether phosphorylation of S14 and poly(ADP-
ribosylation) of glutamate residues depend directly on bioti-
nylation of K12 in histone H4. This uncertainty is being
addressed in ongoing investigations in our laboratory. More-
over, it is not known whether biotinylation of K12 itself
depends on other damage-induced modifications of histones
such as phosphorylation of H2AX (40). Note that histone
H2AX also is a potential target for biotinylation (15). Theo-
retically, biotinylation of K12 in histone H4 might mediate
either DNA repair or apoptosis in response to DSB. We favor
the former explanation, given that biotin deficiency was asso-
ciated with decreased survival of etoposide-treated cells com-
pared with biotin-sufficient controls in the present study. In
this context, the following question must be addressed: Why
FIGURE 2 Treatment with etoposide causes DNA breaks in JAr
cells. Cells were treated with etoposide and DNA breaks were visual-
ized at timed intervals using the TUNEL assay. Positive controls were
treated with DNase I for 10 min.
FIGURE 3 Etoposide does not affect biotinylation of K12 in his-
tone H4 from G1 phase-arrested JAr cells. Cells were arrested in G1
phase using hydroxyurea before treatment with etoposide. Panel A:
G1-arrested cells; panel B: asynchronous cells (control). Cell cycle
arrest was confirmed using flow cytometry (top row), and biotinylation
of K12 in histone H4 was visualized by Western analysis at timed
intervals after etoposide treatment (bottom row); n.d.  not detectable.
FIGURE 4 Immunocytochemistry experiments are consistent with
a rapid and transient decrease in K12-biotinylated histone H4 in JAr cell
nuclei in response to treatment with etoposide. Panel A: Staining of
biotinylation of K12 in histone H4 and cellular compartments in etopo-
side-free JAr cells: a  staining of nuclei using DAPI; b  staining of
K12-biotinylation of histone H4, using a site-specific antibody; c
 staining of cytoplasmic compartment using rhodamine phalloidin; d
 merged image. Panel B: Time course of K12-biotinylation in histone
H4 after addition of etoposide to culture media.
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would biotin deficiency decrease cell survival in response to
DSB, although the damage-related signaling event actually
causes a decrease in K12-biotinylation? We speculate that a
sufficient supply of biotin is essential to allow for an efficient
rebiotinylation of K12 after its rapid transient debiotinylation.
We further speculate that biotinylation of K12 plays a role in
the reassembly of nucleosomes after DNA repair (41).
Current models of chromatin remodeling in response to
DSB are consistent with the findings reported here. Specifi-
cally, it was proposed that DSB are associated with a rapid, yet
transient, relaxation of chromatin structures mediated by his-
tone modifications (42). Relaxation of chromatin gives DNA
repair factors access to sites of DNA breaks. Subsequently,
chromatin recondensation prevents dissociation of the 2 bro-
ken ends of DNA before repair is mediated by ligases. Note
that K12-biotinylated histone H4 is associated with chromatin
condensation such as in pericentromeric heterochromatin
(A. M. Oommen and J. Zempleni, unpublished data). Hence,
a rapid decrease in K12-biotinylation in response to DSB is
likely associated with an opening of chromatin structures,
giving repair proteins access to sites of damage. Subsequent
rebiotinylation of histone H4 is likely associated with recon-
densation of chromatin. Note, however, that this is an un-
tested hypothesis.
Is the response to DSB breaks comparable in transformed
human cell lines and in primary human cells? Previous studies
suggested that the frequency of DNA breaks in response to
X-rays is similar in transformed and primary cells (43). Also,
the kinetics of joining DNA ends is similar in transformed and
primary cells. These observations are consistent with the no-
tion that transformed human cells maintain a normal response
to DSB breaks. Nevertheless, it remains to be formally dem-
onstrated that pathways of DSB repair are identical in the
FIGURE 5 Alterations of K12-biotinylation in histone H4 are spe-
cific for DSB, but are not specific for JAr cells. (A) Jurkat cells were
treated with etoposide, and K12-biotinylation in histone H4 was mon-
itored at timed intervals using Western blot analysis; band intensities
were quantified by gel densitometry. (B) JAr cells were treated with UV,
zeocin, and doxorubicin to cause the formation of thymine dimers,
single-strand breaks, and DSB, respectively. Biotinylation of K12 in
histone H4 was monitored at timed intervals using Western blot anal-
ysis; band intensities were quantified by gel densitometry.
FIGURE 6 Biotin deficiency decreases survival of JAr cells in
response to treatment with etoposide. (A) Extracts from etoposide-free
cells grown in media containing 0.025 and 0.25 nmol/L biotin were
resolved by gel electrophoresis; transblots were probed with strepta-
vidin to visualize biotin-dependent carboxylases. (B) JAr cell were
treated with etoposide and cell survival was monitored at timed inter-
vals using trypan blue exclusion. Values are means  SD, n  10.
*Different from cells cultured in medium containing 0.025 nmol/L biotin,
P  0.05.
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choriocarcinoma cells used in this study and in primary pla-
cental cells.
Taken together, the findings presented here are important
for health professionals, based on the following lines of obser-
vation. Dietary biotin deficiency is relatively rare in humans,
but certain subgroups in the general population are at in-
creased risk for developing biotin deficiency. First, catabolism
of biotin is increased during pregnancy (44); consistent with
this observation is the fairly high prevalence of marginal biotin
deficiency in pregnant women (45,46). Second, some drugs
interfere with biotin metabolism. For example, certain anti-
convulsants and lipoic acid impair biotin transport and distri-
bution, potentially causing biotin deficiency (35). Third, bi-
otin transporter deficiency may cause intracellular biotin
depletion (47). Fourth, mutations of the 2 enzymes (biotini-
dase and holocarboxylase synthetase) that mediate biotinyla-
tion of histones are relatively prevalent in humans. For exam-
ple, the prevalence of biotinidase deficiency is 1 in 60,000 live
births in humans (48). Currently it is unknown whether
dietary biotin deficiency or drug-induced biotin deficiency,
and mutations of genes coding for biotin transporters, biotini-
dase, and holocarboxylase synthetase are associated with an
impaired ability to repair damaged DNA in humans. Similarly,
it is unknown whether supplementation with pharmacologic
dose of biotin enhances an individual’s DNA repair capabili-
ties.
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ONLINE SUPPLEMENTAL TABLE 1 
The abundance of modified histone in response to treatment with etoposide in JAr cells. Histones were quantified by Western blot analysis 
and gel densitometry at timed intervals after addition of etoposide to culture medium.1 
 
 Time after etoposide (min) 
 ____________________________________________________________________________________________________ 
  
Histone2 0 10 20 30 40 50 60 80 100 120 
 
 % of zero-time control 
K12bio H4 100 45 ± 8.6* 53 ± 10* 91 ± 22 96 ± 20 120 ± 20 99 ± 18 139 ± 21 100 ± 8.3 100 ± 17 
S14p H2B 100 112 ± 46 73 ± 13 126 ± 59 321 ± 154 511 ± 299 580 ± 389 880 ± 335*  1250 ± 122* 1474 ± 314* 
K4Me2 H3 100 101 ± 7.4 98 ± 15 98 ± 18 106 ± 25 103 ± 14 104 ± 15 103 ± 15 87 ± 3.2 97 ± 11 
Ub H2A 100 101 ± 7.5 98 ± 15 100 ± 11 93 ± 13 96 ± 10 98 ± 9.3 88 ± 5.9 100 ± 2.5 114 ± 14 
 
1Values are means ± SEM; n = 3 - 5. *Different from zero-time control, P < 0.05. 
2Abbreviations used: K12bio H4, K12-biotinylated histone H4; S14p H2B, S14-phosphorylated histone H2B; K4Me2 H3, K4-dimethylated 
histone H3; Ub H2A, poly(ubiquitinated) histone H2A. 
 
